These final results, together with a preceding report exhibiting that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like habits in mice,two help the idea of focusing on ACKR3 as a unique strategy to modulate the opioid program, which could open up new therapeutic avenues for opioid-related Ailments.At that time, Microsoft Marketing will